News

Morgan Stanley Lifts PT on CG Oncology (CGON) to $56, Keeps an Overweight Rating
CG Oncology, Inc. (NASDAQ:CGON) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts. On June 17, ...
Morgan Stanley: A 7% Yield On The Preferred Shares
Morgan Stanley's Series E preferred shares offer a 7.1% yield, strong coverage, and resilience. Check out my analysis of MS ...
Morgan Stanley Said to Tap Esteve as Equity Syndicate EMEA Head
Morgan Stanley has appointed Javier Esteve as head of equity syndicate for Europe, the Middle East and Africa, according to ...
A team of engineers saved Morgan Stanley more than 280,000 hours this year. The bank says their tool won't take jobs.
A new tool at Morgan Stanley has saved more than 11,000 days of work this year alone and replaced "onerous" rote work.
The market will continue to grind higher over the near-term, says Morgan Stanley's Lisa Shalett
Lisa Shalett, Morgan Stanley Wealth Management CIO, joins 'Closing Bell' to discuss the record market run, why she sees more ...
Morgan Stanley Reshuffles Tech Investment Banking Leadership
Morgan Stanley has appointed Drew Guevara as a global co-head of technology investment banking as part of a broader reshuffle ...
The 3 areas of the stock market to buy as the dollar continues to plummet, Morgan Stanley says
The dollar is dropping, but that's good news for US companies doing business overseas. Morgan Stanley says four sectors ...
Morgan Stanley5d
Morgan Stanley Announces 7.5 Cents Dividend Increase and Authorization of a Renewed $20 Billion Multi-Year Common Equity Share Repurchase Program
Morgan Stanley Announces 7.5 Cents Dividend Increase and Authorization of a Renewed $20 Billion Multi-Year Common Equity ...
NDTV Profit on MSN2h
Nykaa Shares Gain As Morgan Stanley Is 'Overweight' Post Q1 Business Update
NEW DELHI: Shubman Gill etched his name into Indian cricketing history on Sunday, becoming the youngest Indian captain to win ...
Morgan Stanley is all-in on the 'buy America' trade, with one key exception
"Global growth is slowing, but macro is not the markets," Morgan Stanley wrote in recent research.